sodium salicylate has been researched along with bms204352 in 1 studies
Studies (sodium salicylate) | Trials (sodium salicylate) | Recent Studies (post-2010) (sodium salicylate) | Studies (bms204352) | Trials (bms204352) | Recent Studies (post-2010) (bms204352) |
---|---|---|---|---|---|
2,031 | 50 | 171 | 49 | 1 | 12 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, GD; Salvi, R; Sheppard, AM | 1 |
1 other study(ies) available for sodium salicylate and bms204352
Article | Year |
---|---|
Potassium ion channel openers, Maxipost and Retigabine, protect against peripheral salicylate ototoxicity in rats.
Topics: Acoustic Stimulation; Animals; Carbamates; Cochlea; Cochlear Microphonic Potentials; Cytoprotection; Disease Models, Animal; Hearing Loss, Sensorineural; Indoles; KCNQ Potassium Channels; Large-Conductance Calcium-Activated Potassium Channels; Male; Otoacoustic Emissions, Spontaneous; Phenylenediamines; Potassium Channels; Rats, Sprague-Dawley; Sodium Salicylate; Tinnitus | 2015 |